Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04123262
Title Tamoxifen for Well Differentiated Neurodendocrine Tumors and Hormone Receptor Positive Expression
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

pulmonary neuroendocrine tumor

gastrointestinal neuroendocrine tumor

pancreatic endocrine carcinoma

Therapies

Tamoxifen

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.